BTMD - biote Corp.
IEX Last Trade
6.11
0.040 0.655%
Share volume: 692
Last Updated: Thu 26 Dec 2024 08:30:11 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$6.07
0.04
0.66%
Fundamental analysis
47%
Profitability
59%
Dept financing
33%
Liquidity
75%
Performance
32%
Performance
5 Days
2.94%
1 Month
-10.91%
3 Months
9.36%
6 Months
-20.00%
1 Year
17.32%
2 Year
52.43%
Key data
Stock price
$6.11
DAY RANGE
$5.85 - $6.14
52 WEEK RANGE
$3.79 - $8.44
52 WEEK CHANGE
$18.73
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Terry S. Weber
Region: US
Website: biote.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: biote.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Haymaker Acquisition Corp. III does not have any significant operations. The company was incorporated in 2020 and is based in New York, New York.
Recent news